R

Research Solutions of Arizona | Litchfield Park, AZ

Research site
(Unclaimed)
Location
13575 W Indian School Road, Suite 200, Litchfield Park, Arizona, United States of America
Site insights

Top conditions

Ulcer (3 trials)

Ulcerative Colitis (3 trials)

Colitis (3 trials)

Crohn Disease (2 trials)

Angioedema (2 trials)

Top treatments

Mirikizumab
S-600918
Guselkumab
IgPro20

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

6 of 9
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Locations recently updated
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Enrolling
Crohn's Disease
Drug: Mirikizumab

The purpose of this study is to evaluate the efficacy, including clinical remission of guselkumab subcutaneous (SC) induction compared to placebo in...

Active, not recruiting
Colitis, Ulcerative
Other: Placebo
Drug: Guselkumab Dose 1

A study to investigate bowel urgency in adults with moderately to severely active ulcerative colitis (UC) treated with mirikizumab. The study will ha...

Enrolling
Ulcerative Colitis Chronic
Ulcerative Colitis
Drug: Mirikizumab
Locations recently updated

This study is designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative col...

Enrolling
Ulcerative Colitis
Drug: Mirikizumab

The purpose of this study is to investigate the safety, PK / PD, and efficacy of SC CSL312 for prophylactic treatment of pediatric subjects with HAE.

Enrolling
Hereditary Angioedema (HAE)
Biological: CSL312

This phase 3b study will evaluate long-term safety and efficacy of CSL312 (also known as garadacimab) when administered subcutaneously (SC)

Active, not recruiting
Hereditary Angioedema
Biological: CSL312

Trial sponsors

Lilly logo

Lilly (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems